Each May in the U.S. is National Osteoporosis Awareness and Prevention Month which is observed to raise awareness about osteoporosis, promote prevention, and early detection. Bone health is one of the cornerstones of endocrine science and practice, so we felt that this was the perfect issue to take a look at some of the recent...
Three Studies Reveal New Insights into Osteoporosis and Bone Health A trio of studies from the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism examines several issues relating to bone health complications. These papers looked at treatment options to increase bone density in breast cancer patients; the impact of sleeve gastrectomy procedures on bone mass...
A new study has found that bone marrow fat content, as measured by advanced imaging techniques, does not predict the risk of fractures in postmenopausal women. The findings, recently published in The Journal of the Endocrine Society, challenge the idea that bone marrow adipose tissue (BMAT) plays a significant role in fracture susceptibility and suggest...
A Game-Changer in Osteoporosis and Fracture Prevention On behalf of Endocrine Society’s Bone and Mineral Special Interest Group Steering Committee, Vafa Tabatabaie, MD, and Muriel Babey, MD, discuss the importance of fracture liaison services, how they can contribute to an improved quality of life for the patients as well as cost savings for the facility,...
Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare...
A new Scientific Statement released by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system. The use and misuse of opioids are a growing global problem. Opioids are used to treat pain in people with cancer or other conditions (e.g., after an injury or surgery), however,...
In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy for clinicians treating postmenopausal women dealing with a loss of bone density. At the beginning of 2024, the U.S. Food and Drug...
As Endocrine News celebrates Asian American and Pacific Islander Heritage Month, we talk to Joy Y. Wu, MD, PhD, chief of the Division of Endocrinology at Stanford University about her personal and professional journey through the field of endocrinology as well as how her career path has been shaped by her mentors, colleagues, and especially...